Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
Holding CRNX?
Track your performance easily

Crinetics Pharmaceuticals (CRNX) Financial Statements

448 Followers

Crinetics Pharmaceuticals Financial Overview

Crinetics Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.769; its P/E ratio is -14.00; Crinetics Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.91. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 399.00K$ 640.00K-$ 346.00K$ 988.00K
Gross Profit$ 399.00K$ 640.00K-$ 346.00K$ 988.00K
EBIT$ -74.06M$ -73.53M$ -62.66M$ -57.46M$ -50.98M
EBITDA$ -69.45M$ -73.06M$ -62.40M$ -58.43M$ -51.61M
Net Income Common Stockholders$ -74.04M$ -66.93M$ -60.10M$ -57.46M$ -50.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 862.95M$ 900.96M$ 558.55M$ 554.65M$ 264.53M
Total Assets$ 935.53M$ 978.15M$ 635.35M$ 641.54M$ 293.25M
Total Debt$ 53.32M$ 52.50M$ 51.73M$ 52.17M$ 2.56M
Net Debt$ -809.63M$ -848.46M$ -506.83M$ -502.48M$ -261.96M
Total Liabilities$ 104.77M$ 103.22M$ 96.25M$ 93.79M$ 39.14M
Stockholders Equity$ 830.75M$ 874.97M$ 539.11M$ 547.75M$ 254.16M
Cash Flow-
Free Cash Flow$ -46.57M$ -54.19M$ -39.45M$ -44.84M$ -45.97M
Operating Cash Flow$ -45.62M$ -52.86M$ -38.52M$ -41.34M$ -45.73M
Investing Cash Flow$ -53.64M$ 309.00K$ -87.31M$ -193.30M$ 31.44M
Financing Cash Flow$ 5.50M$ 393.57M$ 37.92M$ 337.88M$ 12.66M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

Crinetics Pharmaceuticals Debt to Assets

Crinetics Pharmaceuticals Cash Flow

Crinetics Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis